Attract talent


1 Follower


Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.


Add photos to showcase Acepodia’s culture


Add Acepodia’s values

Insider experiences

Share your experience of working at Acepodia

Sonny Hsiao
CEO, President & Co-Founder
Joseph S. Mccracken
SVP of Business Development
Bill Mackin
Head of Regulatory Affairs

Add your teams to show how people work together at Acepodia

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.